Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Gilead Sciences (NASDAQ:GILD) Research Coverage Started at Barclays

Summary
Barclays assumed coverage on shares of Gilead Sciences (NASDAQ:GILD – Free Report) in a research report report published on Friday morning, MarketBeat Ratings reports. The firm issued an equal weight rating and a $155.00 target price on the biopharmaceutical company’s stock. Several other brokerages have also recently weighed in on GILD. Bank of America set […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

americanbankingnews.comamericanbankingnews.com

Amgen (NASDAQ:AMGN) Research Coverage Started at Barclays

Barclays started coverage on shares of Amgen (NASDAQ:AMGN – Free Report) in a report published on Friday morning,Benzinga reports. The brokerage issued an equal weight rating and a $350.00 price objective on the medical research company’s stock. Several other equities analysts have also commented on AMGN. Wells Fargo & Company increased their target price on […]

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

americanbankingnews.com broke the news in on Monday, February 23, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Gilead Sciences icon

Gilead Sciences

Foster City icon

Foster City

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal